Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Min Chen, Marcelo de Carvalho Bittencourt, Pierre Feugier, Gilbert C. Faure & Marie C. Béné. (2012) Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod. Leukemia & Lymphoma 53:4, pages 739-742.
Read now
Read now
Eyup Ilker Saygili, Nur Aksoy, Mustafa Pehlivan, Tugce Sever, Mehmet Yilmaz, Iclal Geyikli Cimenci & Sacide Pehlivan. (2009) Enzyme levels and G-463A polymorphism of myeloperoxidase in chronic lymphocytic leukemia and multiple myeloma. Leukemia & Lymphoma 50:12, pages 2030-2037.
Read now
Read now
Christine Galustian & Angus Dalgleish. (2009) Lenalidomide: a novel anticancer drug with multiple modalities. Expert Opinion on Pharmacotherapy 10:1, pages 125-133.
Read now
Read now
Jiezhong Chen & Kenneth Raymond. (2008) Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vascular Health and Risk Management 4:6, pages 1265-1272.
Read now
Read now
Articles from other publishers (18)
Yafei Mu, Xijie Fan, Tao Chen, Yuhuan Meng, Junwei Lin, Jiecheng Yuan, Shihui Yu, Yuxin Chen & Lingling Liu. (2023) MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of Clinical Medicine 12:7, pages 2667.
Crossref
Crossref
Wen-Liang Fang, Ming-Huang Chen, Kuo-Hung Huang, Chien-Hsing Lin, Yee Chao, Su-Shun Lo, Anna Fen-Yau Li, Chew-Wun Wu & Yi-Ming Shyr. (2020) The Clinicopathological Features and Genetic Alterations in Epstein–Barr Virus-Associated Gastric Cancer Patients after Curative Surgery. Cancers 12:6, pages 1517.
Crossref
Crossref
Alexander Tamashevski, Yuliya Harmaza, Roman Viter, Daniels Jevdokimovs, Raimond Poplausks, Ekaterina Slobozhanina, Lina Mikoliunaite, Donats Erts, Almira Ramanaviciene & Arunas Ramanavicius. (2019) Zinc oxide nanorod based immunosensing platform for the determination of human leukemic cells. Talanta 200, pages 378-386.
Crossref
Crossref
PEI-PEI LI, KANG LU, LING-YUN GENG, XIANG-XIANG ZHOU, XIN-YU LI & XIN WANG. (2016) Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia. Molecular Medicine Reports 13:6, pages 4934-4938.
Crossref
Crossref
Morteza Aghmesheh, Akshat Saxena & Farshid Niknam. (2015)
BRCA
1
mutation site may be linked with nuclear DNA ploidy in
BRCA
1
-mutated ovarian carcinomas
. Asia-Pacific Journal of Clinical Oncology 11:2, pages 135-141.
Crossref
Crossref
Mohammad Shahjahani, Javad Mohammadiasl, Fatemeh Noroozi, Mohammad Seghatoleslami, Saeid Shahrabi, Fakhredin Saba & Najmaldin Saki. (2015) Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. Cellular Oncology 38:2, pages 93-109.
Crossref
Crossref
C. Rivera, N. Pecuchet, D. Wermert, C. Pricopi, F. Le Pimpec-Barthes, M. Riquet & E. Fabre. (2015) Obésité et cancer bronchique : incidences épidémiologiques, pathologiques et thérapeutiques. Revue de Pneumologie Clinique 71:1, pages 37-43.
Crossref
Crossref
Jiezhong Chen, Mengna Chi, Chen Chen & Xu Dong Zhang. (2013) Obesity and melanoma: Exploring molecular links. Journal of Cellular Biochemistry 114:9, pages 1955-1961.
Crossref
Crossref
Yiping Che, O. Giles Best, Ling Zhong, Kimberley L. Kaufman, Swetlana Mactier, Mark Raftery, Lee M. Graves, Stephen P. Mulligan & Richard I. Christopherson. (2013) Hsp90 Inhibitor SNX-7081 Dysregulates Proteins Involved with DNA Repair and Replication and the Cell Cycle in Human Chronic Lymphocytic Leukemia (CLL) Cells. Journal of Proteome Research 12:4, pages 1710-1722.
Crossref
Crossref
William K. Decker, Nina Shah, Dongxia Xing, Ruth Lapushin, Sufang Li, Simon N. Robinson, Hong Yang, Simrit Parmar, Matthew M. Halpert, Michael J. Keating, John G. Gribben, Jeffrey J. Molldrem, Elizabeth J. Shpall & William G. Wierda. (2012) Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC. PLoS ONE 7:12, pages e51390.
Crossref
Crossref
Matthew S. DavidsJing DengAdrian WiestnerBrian J. Lannutti, Lili WangCatherine J. WuWyndham H. Wilson, Jennifer R. BrownAnthony Letai. (2012) Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia. Blood 120:17, pages 3501-3509.
Crossref
Crossref
Tali M. Johnson. (2012) Treatment and Management of Chronic Lymphocytic Leukemia in the Elderly: What the Pharmacist Clinician Should Know. The Consultant Pharmacist 27:4, pages 274-285.
Crossref
Crossref
Jiezhong Chen. (2012) Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications. World Journal of Virology 1:6, pages 154.
Crossref
Crossref
Ana I. García-Pérez, Eva Galeano, Elena Nieto & Pilar Sancho. (2011) Dequalinium induces human leukemia cell death by affecting the redox balance. Leukemia Research 35:10, pages 1395-1401.
Crossref
Crossref
Lingzhi Zhang, Fiona Murray, Laura Z. Rassenti, Minya Pu, Colleen Kelly, Joan R. Kanter, Andrew Greaves, Karen Messer, Thomas J. Kipps & Paul A. Insel. (2011) Cyclic nucleotide phosphodiesterase 7B mRNA: An unfavorable characteristic in chronic lymphocytic leukemia. International Journal of Cancer 129:5, pages 1162-1169.
Crossref
Crossref
Matthew S. Squires, Laurence Cooke, Victoria Lock, Wenqing Qi, E. Jonathan Lewis, Neil T. Thompson, John F. Lyons & Daruka Mahadevan. (2010) AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples. Molecular Cancer Therapeutics 9:4, pages 920-928.
Crossref
Crossref
Jiezhong Chen & Xu-Feng Huang. (2009) Comment on “Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells” published by Eur J Nutr. European Journal of Nutrition 48:8, pages 505-505.
Crossref
Crossref
Jiezhong Chen & Xu-Feng Huang. (2009) Interleukin-6 Promotes Carcinogenesis Through Multiple Signal Pathways. Digestive Diseases and Sciences 54:6, pages 1373-1374.
Crossref
Crossref